id	sid	tid	token	lemma	pos
cord-297210-b8bl5vq5	1	1	key	key	NNP
cord-297210-b8bl5vq5	1	2	:	:	:
cord-297210-b8bl5vq5	1	3	cord-297210-b8bl5vq5	cord-297210-b8bl5vq5	NNS
cord-297210-b8bl5vq5	1	4	authors	author	NNS
cord-297210-b8bl5vq5	1	5	:	:	:
cord-297210-b8bl5vq5	1	6	Leask	Leask	NNP
cord-297210-b8bl5vq5	1	7	,	,	,
cord-297210-b8bl5vq5	1	8	Andrew	Andrew	NNP
cord-297210-b8bl5vq5	1	9	title	title	NN
cord-297210-b8bl5vq5	1	10	:	:	:
cord-297210-b8bl5vq5	2	1	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	2	2	:	:	:
cord-297210-b8bl5vq5	2	3	is	be	VBZ
cord-297210-b8bl5vq5	2	4	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	2	5	the	the	DT
cord-297210-b8bl5vq5	2	6	killer	killer	NN
cord-297210-b8bl5vq5	2	7	?	?	.
cord-297210-b8bl5vq5	3	1	date	date	NN
cord-297210-b8bl5vq5	3	2	:	:	:
cord-297210-b8bl5vq5	3	3	2020	2020	CD
cord-297210-b8bl5vq5	3	4	-	-	HYPH
cord-297210-b8bl5vq5	3	5	05	05	CD
cord-297210-b8bl5vq5	3	6	-	-	SYM
cord-297210-b8bl5vq5	3	7	13	13	CD
cord-297210-b8bl5vq5	3	8	journal	journal	NN
cord-297210-b8bl5vq5	3	9	:	:	:
cord-297210-b8bl5vq5	3	10	J	J	NNP
cord-297210-b8bl5vq5	3	11	Cell	Cell	NNP
cord-297210-b8bl5vq5	3	12	Commun	Commun	NNP
cord-297210-b8bl5vq5	3	13	Signal	Signal	NNP
cord-297210-b8bl5vq5	3	14	DOI	doi	NN
cord-297210-b8bl5vq5	3	15	:	:	:
cord-297210-b8bl5vq5	4	1	10.1007	10.1007	CD
cord-297210-b8bl5vq5	4	2	/	/	SYM
cord-297210-b8bl5vq5	4	3	s12079	s12079	NNP
cord-297210-b8bl5vq5	4	4	-	-	HYPH
cord-297210-b8bl5vq5	4	5	020	020	CD
cord-297210-b8bl5vq5	4	6	-	-	HYPH
cord-297210-b8bl5vq5	4	7	00569	00569	CD
cord-297210-b8bl5vq5	4	8	-	-	SYM
cord-297210-b8bl5vq5	4	9	0	0	CD
cord-297210-b8bl5vq5	4	10	sha	sha	NN
cord-297210-b8bl5vq5	4	11	:	:	:
cord-297210-b8bl5vq5	5	1	72c5aec8596cfc3ae151431e83c227b8a48035df	72c5aec8596cfc3ae151431e83c227b8a48035df	NNP
cord-297210-b8bl5vq5	5	2	doc_id	doc_id	CD
cord-297210-b8bl5vq5	5	3	:	:	:
cord-297210-b8bl5vq5	6	1	297210	297210	CD
cord-297210-b8bl5vq5	6	2	cord_uid	cord_uid	NNS
cord-297210-b8bl5vq5	6	3	:	:	:
cord-297210-b8bl5vq5	6	4	b8bl5vq5	b8bl5vq5	ADD
cord-297210-b8bl5vq5	7	1	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	7	2	is	be	VBZ
cord-297210-b8bl5vq5	7	3	a	a	DT
cord-297210-b8bl5vq5	7	4	respiratory	respiratory	JJ
cord-297210-b8bl5vq5	7	5	disease	disease	NN
cord-297210-b8bl5vq5	7	6	.	.	.
cord-297210-b8bl5vq5	8	1	A	a	DT
cord-297210-b8bl5vq5	8	2	recent	recent	JJ
cord-297210-b8bl5vq5	8	3	report	report	NN
cord-297210-b8bl5vq5	8	4	in	in	IN
cord-297210-b8bl5vq5	8	5	Lancet	Lancet	NNP
cord-297210-b8bl5vq5	8	6	examined	examine	VBN
cord-297210-b8bl5vq5	8	7	,	,	,
cord-297210-b8bl5vq5	8	8	retrospectively	retrospectively	RB
cord-297210-b8bl5vq5	8	9	,	,	,
cord-297210-b8bl5vq5	8	10	137	137	CD
cord-297210-b8bl5vq5	8	11	patients	patient	NNS
cord-297210-b8bl5vq5	8	12	with	with	IN
cord-297210-b8bl5vq5	8	13	COVD-19	COVD-19	NNP
cord-297210-b8bl5vq5	9	1	.	.	.
cord-297210-b8bl5vq5	9	2	Patients	patient	NNS
cord-297210-b8bl5vq5	9	3	that	that	WDT
cord-297210-b8bl5vq5	9	4	died	die	VBD
cord-297210-b8bl5vq5	9	5	had	have	VBD
cord-297210-b8bl5vq5	9	6	elevated	elevate	VBN
cord-297210-b8bl5vq5	9	7	IL-6	IL-6	NNP
cord-297210-b8bl5vq5	9	8	levels	level	NNS
cord-297210-b8bl5vq5	9	9	and	and	CC
cord-297210-b8bl5vq5	9	10	acute	acute	JJ
cord-297210-b8bl5vq5	9	11	respiratory	respiratory	JJ
cord-297210-b8bl5vq5	9	12	distress	distress	NN
cord-297210-b8bl5vq5	9	13	syndrome	syndrome	NN
cord-297210-b8bl5vq5	9	14	.	.	.
cord-297210-b8bl5vq5	10	1	These	these	DT
cord-297210-b8bl5vq5	10	2	data	datum	NNS
cord-297210-b8bl5vq5	10	3	have	have	VBP
cord-297210-b8bl5vq5	10	4	obvious	obvious	JJ
cord-297210-b8bl5vq5	10	5	implications	implication	NNS
cord-297210-b8bl5vq5	10	6	for	for	IN
cord-297210-b8bl5vq5	10	7	how	how	WRB
cord-297210-b8bl5vq5	10	8	to	to	TO
cord-297210-b8bl5vq5	10	9	control	control	VB
cord-297210-b8bl5vq5	10	10	mortality	mortality	NN
cord-297210-b8bl5vq5	10	11	in	in	IN
cord-297210-b8bl5vq5	10	12	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	10	13	.	.	.
cord-297210-b8bl5vq5	11	1	Effective	effective	JJ
cord-297210-b8bl5vq5	11	2	drugs	drug	NNS
cord-297210-b8bl5vq5	11	3	that	that	WDT
cord-297210-b8bl5vq5	11	4	block	block	VBP
cord-297210-b8bl5vq5	11	5	and	and	CC
cord-297210-b8bl5vq5	11	6	reverse	reverse	VB
cord-297210-b8bl5vq5	11	7	lung	lung	NN
cord-297210-b8bl5vq5	11	8	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	11	9	have	have	VBP
cord-297210-b8bl5vq5	11	10	not	not	RB
cord-297210-b8bl5vq5	11	11	been	be	VBN
cord-297210-b8bl5vq5	11	12	identified	identify	VBN
cord-297210-b8bl5vq5	11	13	.	.	.
cord-297210-b8bl5vq5	12	1	That	that	IN
cord-297210-b8bl5vq5	12	2	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	12	3	is	be	VBZ
cord-297210-b8bl5vq5	12	4	a	a	DT
cord-297210-b8bl5vq5	12	5	respiratory	respiratory	JJ
cord-297210-b8bl5vq5	12	6	disease	disease	NN
cord-297210-b8bl5vq5	12	7	is	be	VBZ
cord-297210-b8bl5vq5	12	8	without	without	IN
cord-297210-b8bl5vq5	12	9	question	question	NN
cord-297210-b8bl5vq5	12	10	.	.	.
cord-297210-b8bl5vq5	13	1	A	a	DT
cord-297210-b8bl5vq5	13	2	recent	recent	JJ
cord-297210-b8bl5vq5	13	3	paper	paper	NN
cord-297210-b8bl5vq5	13	4	published	publish	VBN
cord-297210-b8bl5vq5	13	5	in	in	IN
cord-297210-b8bl5vq5	13	6	Lancet	Lancet	NNP
cord-297210-b8bl5vq5	13	7	(	(	-LRB-
cord-297210-b8bl5vq5	13	8	Zhou	Zhou	NNP
cord-297210-b8bl5vq5	13	9	et	et	NNP
cord-297210-b8bl5vq5	13	10	al	al	NNP
cord-297210-b8bl5vq5	13	11	.	.	NNP
cord-297210-b8bl5vq5	13	12	2020	2020	CD
cord-297210-b8bl5vq5	13	13	)	)	-RRB-
cord-297210-b8bl5vq5	13	14	performed	perform	VBD
cord-297210-b8bl5vq5	13	15	a	a	DT
cord-297210-b8bl5vq5	13	16	retrospective	retrospective	JJ
cord-297210-b8bl5vq5	13	17	study	study	NN
cord-297210-b8bl5vq5	13	18	on	on	IN
cord-297210-b8bl5vq5	13	19	patients	patient	NNS
cord-297210-b8bl5vq5	13	20	at	at	IN
cord-297210-b8bl5vq5	13	21	two	two	CD
cord-297210-b8bl5vq5	13	22	hospitals	hospital	NNS
cord-297210-b8bl5vq5	13	23	in	in	IN
cord-297210-b8bl5vq5	13	24	Wuhan	Wuhan	NNP
cord-297210-b8bl5vq5	13	25	,	,	,
cord-297210-b8bl5vq5	13	26	China	China	NNP
cord-297210-b8bl5vq5	13	27	.	.	.
cord-297210-b8bl5vq5	14	1	This	this	DT
cord-297210-b8bl5vq5	14	2	paper	paper	NN
cord-297210-b8bl5vq5	14	3	was	be	VBD
cord-297210-b8bl5vq5	14	4	extremely	extremely	RB
cord-297210-b8bl5vq5	14	5	data	datum	NNS
cord-297210-b8bl5vq5	14	6	rich	rich	JJ
cord-297210-b8bl5vq5	14	7	,	,	,
cord-297210-b8bl5vq5	14	8	but	but	CC
cord-297210-b8bl5vq5	14	9	several	several	JJ
cord-297210-b8bl5vq5	14	10	points	point	NNS
cord-297210-b8bl5vq5	14	11	that	that	WDT
cord-297210-b8bl5vq5	14	12	were	be	VBD
cord-297210-b8bl5vq5	14	13	not	not	RB
cord-297210-b8bl5vq5	14	14	adequately	adequately	RB
cord-297210-b8bl5vq5	14	15	emphasized	emphasize	VBN
cord-297210-b8bl5vq5	14	16	in	in	IN
cord-297210-b8bl5vq5	14	17	this	this	DT
cord-297210-b8bl5vq5	14	18	manuscript	manuscript	NN
cord-297210-b8bl5vq5	14	19	are	be	VBP
cord-297210-b8bl5vq5	14	20	of	of	IN
cord-297210-b8bl5vq5	14	21	critical	critical	JJ
cord-297210-b8bl5vq5	14	22	importance	importance	NN
cord-297210-b8bl5vq5	14	23	.	.	.
cord-297210-b8bl5vq5	15	1	COVID-19	covid-19	JJ
cord-297210-b8bl5vq5	15	2	patients	patient	NNS
cord-297210-b8bl5vq5	15	3	developed	develop	VBD
cord-297210-b8bl5vq5	15	4	acute	acute	JJ
cord-297210-b8bl5vq5	15	5	respiratory	respiratory	JJ
cord-297210-b8bl5vq5	15	6	distress	distress	NN
cord-297210-b8bl5vq5	15	7	syndrome	syndrome	NN
cord-297210-b8bl5vq5	15	8	(	(	-LRB-
cord-297210-b8bl5vq5	15	9	ARDS	ARDS	NNP
cord-297210-b8bl5vq5	15	10	)	)	-RRB-
cord-297210-b8bl5vq5	15	11	,	,	,
cord-297210-b8bl5vq5	15	12	a	a	DT
cord-297210-b8bl5vq5	15	13	disease	disease	NN
cord-297210-b8bl5vq5	15	14	that	that	WDT
cord-297210-b8bl5vq5	15	15	is	be	VBZ
cord-297210-b8bl5vq5	15	16	characterized	characterize	VBN
cord-297210-b8bl5vq5	15	17	by	by	IN
cord-297210-b8bl5vq5	15	18	rapid	rapid	JJ
cord-297210-b8bl5vq5	15	19	onset	onset	NN
cord-297210-b8bl5vq5	15	20	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	15	21	.	.	.
cord-297210-b8bl5vq5	16	1	In	in	IN
cord-297210-b8bl5vq5	16	2	this	this	DT
cord-297210-b8bl5vq5	16	3	study	study	NN
cord-297210-b8bl5vq5	16	4	,	,	,
cord-297210-b8bl5vq5	16	5	of	of	IN
cord-297210-b8bl5vq5	16	6	191	191	CD
cord-297210-b8bl5vq5	16	7	confirmed	confirm	VBD
cord-297210-b8bl5vq5	16	8	coronavirus	coronavirus	NN
cord-297210-b8bl5vq5	16	9	patients	patient	NNS
cord-297210-b8bl5vq5	16	10	,	,	,
cord-297210-b8bl5vq5	16	11	50/54	50/54	CD
cord-297210-b8bl5vq5	16	12	patients	patient	NNS
cord-297210-b8bl5vq5	16	13	that	that	WDT
cord-297210-b8bl5vq5	16	14	died	die	VBD
cord-297210-b8bl5vq5	16	15	had	have	VBD
cord-297210-b8bl5vq5	16	16	developed	develop	VBN
cord-297210-b8bl5vq5	16	17	ARDS	ARDS	NNP
cord-297210-b8bl5vq5	16	18	;	;	:
cord-297210-b8bl5vq5	16	19	conversely	conversely	RB
cord-297210-b8bl5vq5	16	20	,	,	,
cord-297210-b8bl5vq5	16	21	only	only	RB
cord-297210-b8bl5vq5	16	22	9/137	9/137	CD
cord-297210-b8bl5vq5	16	23	survivors	survivor	NNS
cord-297210-b8bl5vq5	16	24	had	have	VBD
cord-297210-b8bl5vq5	16	25	ARDS	ARDS	NNP
cord-297210-b8bl5vq5	16	26	.	.	.
cord-297210-b8bl5vq5	17	1	Moreover	moreover	RB
cord-297210-b8bl5vq5	17	2	,	,	,
cord-297210-b8bl5vq5	17	3	the	the	DT
cord-297210-b8bl5vq5	17	4	authors	author	NNS
cord-297210-b8bl5vq5	17	5	reported	report	VBD
cord-297210-b8bl5vq5	17	6	that	that	IN
cord-297210-b8bl5vq5	17	7	chronic	chronic	JJ
cord-297210-b8bl5vq5	17	8	obstructive	obstructive	JJ
cord-297210-b8bl5vq5	17	9	pulmonary	pulmonary	JJ
cord-297210-b8bl5vq5	17	10	disease	disease	NN
cord-297210-b8bl5vq5	17	11	(	(	-LRB-
cord-297210-b8bl5vq5	17	12	COPD	COPD	NNP
cord-297210-b8bl5vq5	17	13	)	)	-RRB-
cord-297210-b8bl5vq5	17	14	was	be	VBD
cord-297210-b8bl5vq5	17	15	cormorbid	cormorbid	VBN
cord-297210-b8bl5vq5	17	16	with	with	IN
cord-297210-b8bl5vq5	17	17	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	17	18	(	(	-LRB-
cord-297210-b8bl5vq5	17	19	p	p	NN
cord-297210-b8bl5vq5	17	20	=	=	SYM
cord-297210-b8bl5vq5	17	21	0.056	0.056	CD
cord-297210-b8bl5vq5	17	22	)	)	-RRB-
cord-297210-b8bl5vq5	17	23	.	.	.
cord-297210-b8bl5vq5	18	1	Levels	level	NNS
cord-297210-b8bl5vq5	18	2	of	of	IN
cord-297210-b8bl5vq5	18	3	interleukin	interleukin	NN
cord-297210-b8bl5vq5	18	4	(	(	-LRB-
cord-297210-b8bl5vq5	18	5	IL)-6	IL)-6	NNP
cord-297210-b8bl5vq5	18	6	,	,	,
cord-297210-b8bl5vq5	18	7	a	a	DT
cord-297210-b8bl5vq5	18	8	proinflammatory	proinflammatory	JJ
cord-297210-b8bl5vq5	18	9	cytokine	cytokine	NN
cord-297210-b8bl5vq5	18	10	linked	link	VBN
cord-297210-b8bl5vq5	18	11	with	with	IN
cord-297210-b8bl5vq5	18	12	connective	connective	JJ
cord-297210-b8bl5vq5	18	13	tissue	tissue	NN
cord-297210-b8bl5vq5	18	14	disorders	disorder	NNS
cord-297210-b8bl5vq5	18	15	including	include	VBG
cord-297210-b8bl5vq5	18	16	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	18	17	,	,	,
cord-297210-b8bl5vq5	18	18	were	be	VBD
cord-297210-b8bl5vq5	18	19	significantly	significantly	RB
cord-297210-b8bl5vq5	18	20	higher	high	JJR
cord-297210-b8bl5vq5	18	21	in	in	IN
cord-297210-b8bl5vq5	18	22	patients	patient	NNS
cord-297210-b8bl5vq5	18	23	who	who	WP
cord-297210-b8bl5vq5	18	24	died	die	VBD
cord-297210-b8bl5vq5	18	25	,	,	,
cord-297210-b8bl5vq5	18	26	and	and	CC
cord-297210-b8bl5vq5	18	27	appeared	appear	VBD
cord-297210-b8bl5vq5	18	28	to	to	TO
cord-297210-b8bl5vq5	18	29	increase	increase	VB
cord-297210-b8bl5vq5	18	30	with	with	IN
cord-297210-b8bl5vq5	18	31	disease	disease	NN
cord-297210-b8bl5vq5	18	32	progression	progression	NN
cord-297210-b8bl5vq5	18	33	.	.	.
cord-297210-b8bl5vq5	19	1	In	in	IN
cord-297210-b8bl5vq5	19	2	survivors	survivor	NNS
cord-297210-b8bl5vq5	19	3	,	,	,
cord-297210-b8bl5vq5	19	4	essentially	essentially	RB
cord-297210-b8bl5vq5	19	5	no	no	DT
cord-297210-b8bl5vq5	19	6	alterations	alteration	NNS
cord-297210-b8bl5vq5	19	7	in	in	IN
cord-297210-b8bl5vq5	19	8	IL-6	IL-6	NNP
cord-297210-b8bl5vq5	19	9	levels	level	NNS
cord-297210-b8bl5vq5	19	10	were	be	VBD
cord-297210-b8bl5vq5	19	11	observed	observe	VBN
cord-297210-b8bl5vq5	19	12	.	.	.
cord-297210-b8bl5vq5	20	1	These	these	DT
cord-297210-b8bl5vq5	20	2	data	datum	NNS
cord-297210-b8bl5vq5	20	3	strongly	strongly	RB
cord-297210-b8bl5vq5	20	4	imply	imply	VBP
cord-297210-b8bl5vq5	20	5	that	that	IN
cord-297210-b8bl5vq5	20	6	not	not	RB
cord-297210-b8bl5vq5	20	7	only	only	RB
cord-297210-b8bl5vq5	20	8	is	be	VBZ
cord-297210-b8bl5vq5	20	9	pulmonary	pulmonary	JJ
cord-297210-b8bl5vq5	20	10	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	20	11	a	a	DT
cord-297210-b8bl5vq5	20	12	comorbidity	comorbidity	NN
cord-297210-b8bl5vq5	20	13	for	for	IN
cord-297210-b8bl5vq5	20	14	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	20	15	,	,	,
cord-297210-b8bl5vq5	20	16	but	but	CC
cord-297210-b8bl5vq5	20	17	that	that	IN
cord-297210-b8bl5vq5	20	18	it	-PRON-	PRP
cord-297210-b8bl5vq5	20	19	may	may	MD
cord-297210-b8bl5vq5	20	20	be	be	VB
cord-297210-b8bl5vq5	20	21	the	the	DT
cord-297210-b8bl5vq5	20	22	cause	cause	NN
cord-297210-b8bl5vq5	20	23	of	of	IN
cord-297210-b8bl5vq5	20	24	mortality	mortality	NN
cord-297210-b8bl5vq5	20	25	for	for	IN
cord-297210-b8bl5vq5	20	26	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	20	27	.	.	.
cord-297210-b8bl5vq5	21	1	It	-PRON-	PRP
cord-297210-b8bl5vq5	21	2	also	also	RB
cord-297210-b8bl5vq5	21	3	suggests	suggest	VBZ
cord-297210-b8bl5vq5	21	4	that	that	IN
cord-297210-b8bl5vq5	21	5	it	-PRON-	PRP
cord-297210-b8bl5vq5	21	6	may	may	MD
cord-297210-b8bl5vq5	21	7	be	be	VB
cord-297210-b8bl5vq5	21	8	reasonable	reasonable	JJ
cord-297210-b8bl5vq5	21	9	to	to	TO
cord-297210-b8bl5vq5	21	10	explore	explore	VB
cord-297210-b8bl5vq5	21	11	if	if	IN
cord-297210-b8bl5vq5	21	12	IL-6	IL-6	NNP
cord-297210-b8bl5vq5	21	13	antagonists	antagonist	NNS
cord-297210-b8bl5vq5	21	14	may	may	MD
cord-297210-b8bl5vq5	21	15	be	be	VB
cord-297210-b8bl5vq5	21	16	useful	useful	JJ
cord-297210-b8bl5vq5	21	17	to	to	TO
cord-297210-b8bl5vq5	21	18	treat	treat	VB
cord-297210-b8bl5vq5	21	19	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	21	20	.	.	.
cord-297210-b8bl5vq5	22	1	In	in	IN
cord-297210-b8bl5vq5	22	2	any	any	DT
cord-297210-b8bl5vq5	22	3	event	event	NN
cord-297210-b8bl5vq5	22	4	,	,	,
cord-297210-b8bl5vq5	22	5	these	these	DT
cord-297210-b8bl5vq5	22	6	data	datum	NNS
cord-297210-b8bl5vq5	22	7	strongly	strongly	RB
cord-297210-b8bl5vq5	22	8	support	support	VBP
cord-297210-b8bl5vq5	22	9	the	the	DT
cord-297210-b8bl5vq5	22	10	contention	contention	NN
cord-297210-b8bl5vq5	22	11	that	that	IN
cord-297210-b8bl5vq5	22	12	development	development	NN
cord-297210-b8bl5vq5	22	13	of	of	IN
cord-297210-b8bl5vq5	22	14	anti	anti	JJ
cord-297210-b8bl5vq5	22	15	-	-	JJ
cord-297210-b8bl5vq5	22	16	fibrotic	fibrotic	JJ
cord-297210-b8bl5vq5	22	17	agents	agent	NNS
cord-297210-b8bl5vq5	22	18	is	be	VBZ
cord-297210-b8bl5vq5	22	19	imperative	imperative	JJ
cord-297210-b8bl5vq5	22	20	not	not	RB
cord-297210-b8bl5vq5	22	21	only	only	RB
cord-297210-b8bl5vq5	22	22	to	to	TO
cord-297210-b8bl5vq5	22	23	affect	affect	VB
cord-297210-b8bl5vq5	22	24	diseases	disease	NNS
cord-297210-b8bl5vq5	22	25	such	such	JJ
cord-297210-b8bl5vq5	22	26	as	as	IN
cord-297210-b8bl5vq5	22	27	scleroderma	scleroderma	NN
cord-297210-b8bl5vq5	22	28	,	,	,
cord-297210-b8bl5vq5	22	29	idiopathic	idiopathic	JJ
cord-297210-b8bl5vq5	22	30	pulmonary	pulmonary	JJ
cord-297210-b8bl5vq5	22	31	fibrosis	fibrosis	NN
cord-297210-b8bl5vq5	22	32	,	,	,
cord-297210-b8bl5vq5	22	33	Duchenne	Duchenne	NNP
cord-297210-b8bl5vq5	22	34	's	's	POS
cord-297210-b8bl5vq5	22	35	muscular	muscular	JJ
cord-297210-b8bl5vq5	22	36	dystrophy	dystrophy	NN
cord-297210-b8bl5vq5	22	37	and	and	CC
cord-297210-b8bl5vq5	22	38	metastatic	metastatic	JJ
cord-297210-b8bl5vq5	22	39	cancers	cancer	NNS
cord-297210-b8bl5vq5	22	40	,	,	,
cord-297210-b8bl5vq5	22	41	but	but	CC
cord-297210-b8bl5vq5	22	42	is	be	VBZ
cord-297210-b8bl5vq5	22	43	also	also	RB
cord-297210-b8bl5vq5	22	44	necessary	necessary	JJ
cord-297210-b8bl5vq5	22	45	to	to	TO
cord-297210-b8bl5vq5	22	46	treat	treat	VB
cord-297210-b8bl5vq5	22	47	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	22	48	.	.	.
cord-297210-b8bl5vq5	23	1	Open	open	VB
cord-297210-b8bl5vq5	23	2	Access	Access	NNP
cord-297210-b8bl5vq5	24	1	This	this	DT
cord-297210-b8bl5vq5	24	2	article	article	NN
cord-297210-b8bl5vq5	24	3	is	be	VBZ
cord-297210-b8bl5vq5	24	4	licensed	license	VBN
cord-297210-b8bl5vq5	24	5	under	under	IN
cord-297210-b8bl5vq5	24	6	a	a	DT
cord-297210-b8bl5vq5	24	7	Creative	Creative	NNP
cord-297210-b8bl5vq5	24	8	Commons	Commons	NNP
cord-297210-b8bl5vq5	24	9	Attribution	Attribution	NNP
cord-297210-b8bl5vq5	24	10	4.0	4.0	CD
cord-297210-b8bl5vq5	24	11	International	International	NNP
cord-297210-b8bl5vq5	24	12	License	License	NNP
cord-297210-b8bl5vq5	24	13	,	,	,
cord-297210-b8bl5vq5	24	14	which	which	WDT
cord-297210-b8bl5vq5	24	15	permits	permit	VBZ
cord-297210-b8bl5vq5	24	16	use	use	NN
cord-297210-b8bl5vq5	24	17	,	,	,
cord-297210-b8bl5vq5	24	18	sharing	sharing	NN
cord-297210-b8bl5vq5	24	19	,	,	,
cord-297210-b8bl5vq5	24	20	adaptation	adaptation	NN
cord-297210-b8bl5vq5	24	21	,	,	,
cord-297210-b8bl5vq5	24	22	distribution	distribution	NN
cord-297210-b8bl5vq5	24	23	and	and	CC
cord-297210-b8bl5vq5	24	24	reproduction	reproduction	NN
cord-297210-b8bl5vq5	24	25	in	in	IN
cord-297210-b8bl5vq5	24	26	any	any	DT
cord-297210-b8bl5vq5	24	27	medium	medium	NN
cord-297210-b8bl5vq5	24	28	or	or	CC
cord-297210-b8bl5vq5	24	29	format	format	NN
cord-297210-b8bl5vq5	24	30	,	,	,
cord-297210-b8bl5vq5	24	31	as	as	RB
cord-297210-b8bl5vq5	24	32	long	long	RB
cord-297210-b8bl5vq5	24	33	as	as	IN
cord-297210-b8bl5vq5	24	34	you	-PRON-	PRP
cord-297210-b8bl5vq5	24	35	give	give	VBP
cord-297210-b8bl5vq5	24	36	appropriate	appropriate	JJ
cord-297210-b8bl5vq5	24	37	credit	credit	NN
cord-297210-b8bl5vq5	24	38	to	to	IN
cord-297210-b8bl5vq5	24	39	the	the	DT
cord-297210-b8bl5vq5	24	40	original	original	JJ
cord-297210-b8bl5vq5	24	41	author(s	author(s	NNP
cord-297210-b8bl5vq5	24	42	)	)	-RRB-
cord-297210-b8bl5vq5	24	43	and	and	CC
cord-297210-b8bl5vq5	24	44	the	the	DT
cord-297210-b8bl5vq5	24	45	source	source	NN
cord-297210-b8bl5vq5	24	46	,	,	,
cord-297210-b8bl5vq5	24	47	provide	provide	VB
cord-297210-b8bl5vq5	24	48	a	a	DT
cord-297210-b8bl5vq5	24	49	link	link	NN
cord-297210-b8bl5vq5	24	50	to	to	IN
cord-297210-b8bl5vq5	24	51	the	the	DT
cord-297210-b8bl5vq5	24	52	Creative	Creative	NNP
cord-297210-b8bl5vq5	24	53	Commons	Commons	NNP
cord-297210-b8bl5vq5	24	54	licence	licence	NN
cord-297210-b8bl5vq5	24	55	,	,	,
cord-297210-b8bl5vq5	24	56	and	and	CC
cord-297210-b8bl5vq5	24	57	indicate	indicate	VBP
cord-297210-b8bl5vq5	24	58	if	if	IN
cord-297210-b8bl5vq5	24	59	changes	change	NNS
cord-297210-b8bl5vq5	24	60	were	be	VBD
cord-297210-b8bl5vq5	24	61	made	make	VBN
cord-297210-b8bl5vq5	24	62	.	.	.
cord-297210-b8bl5vq5	25	1	The	the	DT
cord-297210-b8bl5vq5	25	2	images	image	NNS
cord-297210-b8bl5vq5	25	3	or	or	CC
cord-297210-b8bl5vq5	25	4	other	other	JJ
cord-297210-b8bl5vq5	25	5	third	third	JJ
cord-297210-b8bl5vq5	25	6	party	party	NN
cord-297210-b8bl5vq5	25	7	material	material	NN
cord-297210-b8bl5vq5	25	8	in	in	IN
cord-297210-b8bl5vq5	25	9	this	this	DT
cord-297210-b8bl5vq5	25	10	article	article	NN
cord-297210-b8bl5vq5	25	11	are	be	VBP
cord-297210-b8bl5vq5	25	12	included	include	VBN
cord-297210-b8bl5vq5	25	13	in	in	IN
cord-297210-b8bl5vq5	25	14	the	the	DT
cord-297210-b8bl5vq5	25	15	article	article	NN
cord-297210-b8bl5vq5	25	16	's	's	POS
cord-297210-b8bl5vq5	25	17	Creative	Creative	NNP
cord-297210-b8bl5vq5	25	18	Commons	Commons	NNP
cord-297210-b8bl5vq5	25	19	licence	licence	NN
cord-297210-b8bl5vq5	25	20	,	,	,
cord-297210-b8bl5vq5	25	21	unless	unless	IN
cord-297210-b8bl5vq5	25	22	indicated	indicate	VBN
cord-297210-b8bl5vq5	25	23	otherwise	otherwise	RB
cord-297210-b8bl5vq5	25	24	in	in	IN
cord-297210-b8bl5vq5	25	25	a	a	DT
cord-297210-b8bl5vq5	25	26	credit	credit	NN
cord-297210-b8bl5vq5	25	27	line	line	NN
cord-297210-b8bl5vq5	25	28	to	to	IN
cord-297210-b8bl5vq5	25	29	the	the	DT
cord-297210-b8bl5vq5	25	30	material	material	NN
cord-297210-b8bl5vq5	25	31	.	.	.
cord-297210-b8bl5vq5	26	1	If	if	IN
cord-297210-b8bl5vq5	26	2	material	material	NN
cord-297210-b8bl5vq5	26	3	is	be	VBZ
cord-297210-b8bl5vq5	26	4	not	not	RB
cord-297210-b8bl5vq5	26	5	included	include	VBN
cord-297210-b8bl5vq5	26	6	in	in	IN
cord-297210-b8bl5vq5	26	7	the	the	DT
cord-297210-b8bl5vq5	26	8	article	article	NN
cord-297210-b8bl5vq5	26	9	's	's	POS
cord-297210-b8bl5vq5	26	10	Creative	Creative	NNP
cord-297210-b8bl5vq5	26	11	Commons	Commons	NNP
cord-297210-b8bl5vq5	26	12	licence	licence	NN
cord-297210-b8bl5vq5	26	13	and	and	CC
cord-297210-b8bl5vq5	26	14	your	-PRON-	PRP$
cord-297210-b8bl5vq5	26	15	intended	intend	VBN
cord-297210-b8bl5vq5	26	16	use	use	NN
cord-297210-b8bl5vq5	26	17	is	be	VBZ
cord-297210-b8bl5vq5	26	18	not	not	RB
cord-297210-b8bl5vq5	26	19	permitted	permit	VBN
cord-297210-b8bl5vq5	26	20	by	by	IN
cord-297210-b8bl5vq5	26	21	statutory	statutory	JJ
cord-297210-b8bl5vq5	26	22	regulation	regulation	NN
cord-297210-b8bl5vq5	26	23	or	or	CC
cord-297210-b8bl5vq5	26	24	exceeds	exceed	VBZ
cord-297210-b8bl5vq5	26	25	the	the	DT
cord-297210-b8bl5vq5	26	26	permitted	permit	VBN
cord-297210-b8bl5vq5	26	27	use	use	NN
cord-297210-b8bl5vq5	26	28	,	,	,
cord-297210-b8bl5vq5	26	29	you	-PRON-	PRP
cord-297210-b8bl5vq5	26	30	will	will	MD
cord-297210-b8bl5vq5	26	31	need	need	VB
cord-297210-b8bl5vq5	26	32	to	to	TO
cord-297210-b8bl5vq5	26	33	obtain	obtain	VB
cord-297210-b8bl5vq5	26	34	permission	permission	NN
cord-297210-b8bl5vq5	26	35	directly	directly	RB
cord-297210-b8bl5vq5	26	36	from	from	IN
cord-297210-b8bl5vq5	26	37	the	the	DT
cord-297210-b8bl5vq5	26	38	copyright	copyright	NN
cord-297210-b8bl5vq5	26	39	holder	holder	NN
cord-297210-b8bl5vq5	26	40	.	.	.
cord-297210-b8bl5vq5	27	1	To	to	TO
cord-297210-b8bl5vq5	27	2	view	view	VB
cord-297210-b8bl5vq5	27	3	a	a	DT
cord-297210-b8bl5vq5	27	4	copy	copy	NN
cord-297210-b8bl5vq5	27	5	of	of	IN
cord-297210-b8bl5vq5	27	6	this	this	DT
cord-297210-b8bl5vq5	27	7	licence	licence	NN
cord-297210-b8bl5vq5	27	8	,	,	,
cord-297210-b8bl5vq5	27	9	visit	visit	VB
cord-297210-b8bl5vq5	27	10	http://creativecommons.org/licenses/by/4.0/.	http://creativecommons.org/licenses/by/4.0/.	NNP
cord-297210-b8bl5vq5	27	11	Clinical	clinical	JJ
cord-297210-b8bl5vq5	27	12	course	course	NN
cord-297210-b8bl5vq5	27	13	and	and	CC
cord-297210-b8bl5vq5	27	14	risk	risk	NN
cord-297210-b8bl5vq5	27	15	factors	factor	NNS
cord-297210-b8bl5vq5	27	16	for	for	IN
cord-297210-b8bl5vq5	27	17	mortality	mortality	NN
cord-297210-b8bl5vq5	27	18	of	of	IN
cord-297210-b8bl5vq5	27	19	adult	adult	NN
cord-297210-b8bl5vq5	27	20	inpatients	inpatient	NNS
cord-297210-b8bl5vq5	27	21	with	with	IN
cord-297210-b8bl5vq5	27	22	COVID-19	COVID-19	NNP
cord-297210-b8bl5vq5	27	23	in	in	IN
cord-297210-b8bl5vq5	27	24	Wuhan	Wuhan	NNP
cord-297210-b8bl5vq5	27	25	,	,	,
cord-297210-b8bl5vq5	27	26	China	China	NNP
cord-297210-b8bl5vq5	27	27	:	:	:
cord-297210-b8bl5vq5	28	1	a	a	DT
cord-297210-b8bl5vq5	28	2	retrospective	retrospective	JJ
cord-297210-b8bl5vq5	28	3	cohort	cohort	NN
cord-297210-b8bl5vq5	28	4	study	study	NN
cord-297210-b8bl5vq5	28	5	Publisher	Publisher	NNP
cord-297210-b8bl5vq5	28	6	's	's	POS
cord-297210-b8bl5vq5	28	7	note	note	NN
cord-297210-b8bl5vq5	29	1	Springer	Springer	NNP
cord-297210-b8bl5vq5	29	2	Nature	Nature	NNP
cord-297210-b8bl5vq5	29	3	remains	remain	VBZ
cord-297210-b8bl5vq5	29	4	neutral	neutral	JJ
cord-297210-b8bl5vq5	29	5	with	with	IN
cord-297210-b8bl5vq5	29	6	regard	regard	NN
cord-297210-b8bl5vq5	29	7	to	to	IN
cord-297210-b8bl5vq5	29	8	jurisdictional	jurisdictional	JJ
cord-297210-b8bl5vq5	29	9	claims	claim	NNS
cord-297210-b8bl5vq5	29	10	in	in	IN
cord-297210-b8bl5vq5	29	11	published	publish	VBN
cord-297210-b8bl5vq5	29	12	maps	map	NNS
cord-297210-b8bl5vq5	29	13	and	and	CC
cord-297210-b8bl5vq5	29	14	institutional	institutional	JJ
cord-297210-b8bl5vq5	29	15	affiliations	affiliation	NNS